120 related articles for article (PubMed ID: 33612089)
41. Expanded cytologic criteria for the diagnosis of adenocarcinoma in situ of the cervix and related lesions.
Bousfield L; Pacey F; Young Q; Krumins I; Osborn R
Acta Cytol; 1980; 24(4):283-96. PubMed ID: 6932140
[TBL] [Abstract][Full Text] [Related]
42. The status and distance of cone biopsy margins as a predictor of excision adequacy for endocervical adenocarcinoma in situ.
Goldstein NS; Mani A
Am J Clin Pathol; 1998 Jun; 109(6):727-32. PubMed ID: 9620030
[TBL] [Abstract][Full Text] [Related]
43. Endocervical adenocarcinoma in situ: an analysis of cellular features.
Biscotti CV; Gero MA; Toddy SM; Fischler DF; Easley KA
Diagn Cytopathol; 1997 Nov; 17(5):326-32. PubMed ID: 9360044
[TBL] [Abstract][Full Text] [Related]
44. Severe cervical glandular cell lesions and severe cervical combined lesions: predictive value of the papanicolaou smear.
van Aspert-van Erp AJ; Smedts FM; Vooijs GP
Cancer; 2004 Aug; 102(4):210-7. PubMed ID: 15368312
[TBL] [Abstract][Full Text] [Related]
45. Colloid carcinoma of the uterine cervix: a case report with respect to immunohistochemical analyses.
Ishida M; Iwai M; Kagotani A; Yoshida K; Okabe H
Int J Gynecol Pathol; 2014 May; 33(3):248-52. PubMed ID: 24681734
[TBL] [Abstract][Full Text] [Related]
46. The immunohistochemical assessment of HPV related adenocarcinoma: pathologic and clinical prognostic significance.
Balan R; Căruntu ID; Amălinei C
Curr Pharm Des; 2013; 19(8):1430-8. PubMed ID: 23016776
[TBL] [Abstract][Full Text] [Related]
47. Apoptotic bodies: a consistent morphologic feature of endocervical adenocarcinoma in situ.
Biscotti CV; Hart WR
Am J Surg Pathol; 1998 Apr; 22(4):434-9. PubMed ID: 9537470
[TBL] [Abstract][Full Text] [Related]
48. Endocervical glandular neoplasia associated with lobular endocervical glandular hyperplasia is HPV-independent and correlates with carbonic anhydrase-IX expression: a Gynaecological Oncology Group Study.
Liao SY; Rodgers WH; Kauderer J; Darcy KM; Carter R; Susumu N; Nagao S; Walker JL; Hatae M; Stanbridge EJ
Br J Cancer; 2013 Feb; 108(3):613-20. PubMed ID: 23299542
[TBL] [Abstract][Full Text] [Related]
49. Uterine cervical carcinomas associated with lobular endocervical glandular hyperplasia.
Tsuji T; Togami S; Nomoto M; Higashi M; Fukukura Y; Kamio M; Yonezawa S; Douchi T
Histopathology; 2011 Jul; 59(1):55-62. PubMed ID: 21771026
[TBL] [Abstract][Full Text] [Related]
50. Challenges in the Pap diagnosis of endocervical adenocarcinoma in situ.
Niu S; Molberg K; Thibodeaux J; Rivera-Colon G; Hinson S; Zheng W; Lucas E
J Am Soc Cytopathol; 2019; 8(3):141-148. PubMed ID: 31097290
[TBL] [Abstract][Full Text] [Related]
51. Mammaglobin expression in the female genital tract: immunohistochemical analysis in benign and neoplastic endocervix and endometrium.
Onuma K; Dabbs DJ; Bhargava R
Int J Gynecol Pathol; 2008 Jul; 27(3):418-25. PubMed ID: 18580321
[TBL] [Abstract][Full Text] [Related]
52. Expression of CLDN1 and CLDN10 in lung adenocarcinoma in situ and invasive lepidic predominant adenocarcinoma.
Zhang Z; Wang A; Sun B; Zhan Z; Chen K; Wang C
J Cardiothorac Surg; 2013 Apr; 8():95. PubMed ID: 23591077
[TBL] [Abstract][Full Text] [Related]
53. Endocervical adenocarcinoma in situ of tubal type and its relation to atypical tubal metaplasia.
Schlesinger C; Silverberg SG
Int J Gynecol Pathol; 1999 Jan; 18(1):1-4. PubMed ID: 9891235
[TBL] [Abstract][Full Text] [Related]
54. Glandular lesions of the uterine cervix: prognostic implications of human papillomavirus status.
Anciaux D; Lawrence WD; Gregoire L
Int J Gynecol Pathol; 1997 Apr; 16(2):103-10. PubMed ID: 9100062
[TBL] [Abstract][Full Text] [Related]
55. Increased diagnostic accuracy of atypical glandular cells in cervical liquid-based cytology using cell blocks.
Risse EK; Holierhoek JP; Meijer-Marres EM; Ouwerkerk-Noordam E; Boon ME
Cytopathology; 2011 Aug; 22(4):253-60. PubMed ID: 20726867
[TBL] [Abstract][Full Text] [Related]
56. Cytologic features of squamous cell carcinoma in situ involving endocervical glands in endocervical cytobrush specimens.
Selvaggi SM
Acta Cytol; 1994; 38(5):687-92. PubMed ID: 8091898
[TBL] [Abstract][Full Text] [Related]
57. Reproducible and clinically meaningful differential diagnosis is possible between lobular endocervical glandular hyperplasia and 'adenoma malignum' based on common histopathological criteria.
Tsuda H; Mikami Y; Kaku T; Hasegawa T; Akiyama F; Ohishi Y; Sasajima Y; Kasamatsu T
Pathol Int; 2005 Jul; 55(7):412-8. PubMed ID: 15982216
[TBL] [Abstract][Full Text] [Related]
58. Comparative cytologic features of adenocarcinoma in situ of the uterine cervix.
Lee KR; Manna EA; Jones MA
Acta Cytol; 1991; 35(1):117-26. PubMed ID: 1994620
[TBL] [Abstract][Full Text] [Related]
59. Biomarker identification and trans-regulatory network analyses in esophageal adenocarcinoma and Barrett's esophagus.
Lv J; Guo L; Wang JH; Yan YZ; Zhang J; Wang YY; Yu Y; Huang YF; Zhao HP
World J Gastroenterol; 2019 Jan; 25(2):233-244. PubMed ID: 30670912
[TBL] [Abstract][Full Text] [Related]
60. Expression of the MN antigen in cervical papanicolaou smears is an early diagnostic biomarker of cervical dysplasia.
Liao SY; Stanbridge EJ
Cancer Epidemiol Biomarkers Prev; 1996 Jul; 5(7):549-57. PubMed ID: 8827360
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
